"instanceType","label","name","id","text","description","uuid:ID"
"OBJECTIVE","","OBJ1","Objective_1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Main objective","957840f7-58e3-4d2a-b363-17bfc3fcb876"
"OBJECTIVE","","OBJ2","Objective_2","To document the safety profile of the xanomeline TTS.","Safety","352f3842-6ca4-41d6-8bb2-1d93a244001b"
"OBJECTIVE","","OBJ3","Objective_3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Behaviour","9a8c105f-b934-49d3-8182-83c0c0315883"
